Cost-effectiveness of resistance-guided therapy for Mycoplasma genitalium in Australia.

Autor: Adawiyah, Rabiah Al^1,2 (AUTHOR) Biah.Adawiyah@monash.edu, Bradshaw, Catriona S.^1,2,3 (AUTHOR), Vodstrcil, Lenka A.^1,2,3 (AUTHOR), Fairley, Christopher K.^1,2 (AUTHOR), Zhang, Lei^1,2,4 (AUTHOR) lei.zhang1@monash.edu, Ong, Jason J.^1,2,5 (AUTHOR) Jason.Ong@monash.edu

Publikováno v: Scientific Reports. 6/4/2024, Vol. 14 Issue 1, p1-10. 10p.

Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.

Autor: Khosropour CM; From the *Department of Epidemiology, University of Washington, Seattle, WA; †Group Health Research Institute, Seattle, WA; ‡Departments of Global Health and §Medicine, University of Washington, Seattle, WA; and ¶Public Health-Seattle and King County HIV/STD Program, Seattle, WA., Broad JM, Scholes D, Saint-Johnson J, Manhart LE, Golden MR

Publikováno v: Sexually transmitted diseases [Sex Transm Dis] 2014 Nov; Vol. 41 (11), pp. 665-70.

Chlamydia screening coverage estimates derived using healthcare effectiveness data and information system procedures and indirect estimation vary substantially.

Autor: Broad JM; University of Washington, Seattle, WA, USA., Manhart LE, Kerani RP, Scholes D, Hughes JP, Golden MR

Publikováno v: Sexually transmitted diseases [Sex Transm Dis] 2013 Apr; Vol. 40 (4), pp. 292-7.

An STI upsurge requires a nimble approach to care.

Autor: Kelly, Kelsie¹, Sommer, Michelle¹, Vail, Belinda¹ bvail@kumc.edu

Publikováno v: Journal of Family Practice. Jul2023, Vol. 72 Issue 6, pE1-E12. 12p.

Pathogenicity and virulence of Mycoplasma genitalium: Unraveling Ariadne's Thread.

Autor: Wu Yueyue¹, Xiu Feichen¹, Xi Yixuan¹, Liu Lu¹, Chen Yiwen¹, You Xiaoxing¹ youxiaoxing@usc.edu.cn

Publikováno v: Virulence. Dec2022, Vol. 13 Issue 1, p1161-1183. 23p.